Medicine

All Articles

Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon location

.Nature Medicine, Posted online: 18 September 2024 doi:10.1038/ s41591-024-03300-3Genomic and also e...

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative boob cancer cells: a phase 2 flexible test

.PatientsPatients in friends An as well as B were actually qualified for registration if they were a...

Targeted treatment guided by spreading tumor DNA study in advanced gastrointestinal growths

.Attribute Medication, Posted online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the empiri...

Countering the impact of the temperature dilemma on health will demand records

.As dramatically climbing global temperatures endanger the wellness as well as well-being of populac...

Exposure to excessive warmth enhances perinatal death in sub-Saharan Africa

.Publisheru00e2 $ s note Springer Attribute stays neutral with regard to supervisory insurance claim...

Data- driven risk stratification and also precision management of lung nodules found on chest calculated tomography

.Participant recruitmentThe retrospective key dataset made up participants coming from the MCC in th...

Datopotamab\u00e2 $ \"deruxtecan in early-stage boob cancer cells: the sequential a number of job randomized I-SPY2.2 phase 2 trial

.Contending interests.J.L.M. discloses institutional research funding coming from AstraZeneca, Seage...

Trastuzumab deruxtecan in HER2-positive advanced breast cancer cells along with or even without human brain metastases: a phase 3b\/4 test

.Attributes Medicine, Posted online: 13 September 2024 doi:10.1038/ s41591-024-03261-7In the non-ran...

Accelerating ASO treatments from progression to execution

.Contending enthusiasms.R.S., M.S., H.G. and also A.A.R. are actually planners of the 1M1M initiativ...

Post- commendation proof production: a common task for healthcare

.Nature Medication, Posted online: 13 September 2024 doi:10.1038/ s41591-024-03241-xPost-approval do...